Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216017 · ClinicalTrials.gov registry record · Phase 2
Glenohumeral Cortisone Injection
A Phase 2 study of Humeral Fractures, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT04216017: Completed Phase 2 study of Humeral Fractures, sponsored by University of Washington.
NCT04216017 is a Phase 2 study of Humeral Fractures that has completed, run by University of Washington. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04216017, a Phase 2 study of Humeral Fractures, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.
Primary Outcome
Outcome Instrument high is good low is bad 0-100 The ASES is a condition-specific scale that is intended to measure functional limitations and pain of the shoulder.
Conditions Studied
Interventions
- DRUG Lidocaine
- DRUG kenalog
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-05-01 |
| Phase | Phase 2 |
What the finished NCT04216017 record still lists
NCT04216017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Humeral Fractures appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine is the first listed.
NCT04216017 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04216017 about?
NCT04216017 is a clinical study titled "Glenohumeral Cortisone Injection". The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.
What is the current status of trial NCT04216017?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2020-01-01. Estimated completion is 2022-05-01.
What conditions does trial NCT04216017 study?
This clinical trial studies the following conditions: Humeral Fractures.
What interventions are being tested in trial NCT04216017?
The interventions under investigation include: Lidocaine (DRUG), kenalog (DRUG).
Who is sponsoring clinical trial NCT04216017?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04216017 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Humeral Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04216017's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI